BAH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Booz Allen Hamilton Holding Corp (BAH) is not a strong buy at this moment for a beginner investor with a long-term focus. While there are some positive indicators such as insider and hedge fund buying, the technical analysis and options data suggest a lack of strong upward momentum in the short term. Additionally, financial performance shows mixed results with declining revenue, which could be a concern for long-term growth. Analysts' ratings are mostly neutral, and there are no significant catalysts to justify immediate action.
The technical indicators are mixed to bearish. The MACD is below 0 and negatively contracting, suggesting weak momentum. RSI is neutral at 53.623, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Key resistance levels are at 80.947 and 82.882, while support levels are at 74.685 and 72.751. The stock has a 70% chance of declining in the short term (-1.3% in the next day, -5.01% in the next week).
Insiders and hedge funds are significantly increasing their buying activity, with insider buying up 1555.13% and hedge fund buying up 107.57%. The company has raised FY26 EPS guidance by 9%, and analysts expect potential benefits from defense spending growth.
Revenue has declined by -10.19% YoY in Q3 2026, and gross margin has dropped by -5.27% YoY. Analysts highlight limited topline visibility and potential downside in the company's civil business. Options data shows bearish sentiment, and technical indicators do not support a strong upward trend.
In Q3 2026, revenue dropped by -10.19% YoY to $2.62 billion, while net income increased by 6.53% YoY to $198 million. EPS grew by 12.41% YoY to 1.63, but gross margin decreased by -5.27% YoY to 51.03. The financials indicate mixed performance with declining revenue but improved profitability.
Analyst ratings are mostly neutral, with price targets ranging from $90 to $115. UBS, Stifel, Jefferies, and others maintain Hold or Neutral ratings, citing limited topline visibility, revenue contraction, and mixed financial results. While some analysts see potential benefits from defense spending, there is no strong consensus for a buy recommendation.
